Feasibility of Permacol Use in Infected Fields
To Examine the Feasibility of Using Permacol® Surgical Implant in the Repair of Abdominal Wall Defects After Removal of Chronic Infect Prosthetic Mesh
Sponsor: Medtronic - MITG
Terminated
Slow enrollment due to strict eligibility criteria
Other terminated trials from Medtronic - MITG
Other Hernia trials with similar outcome
Listed as NCT00820040, this PHASE2 trial focuses on Hernia and remains terminated or withdrawn. Sponsored by Medtronic - MITG, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
Status: Withheld → Terminated · Phase: None → PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Jul 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic - MITG
For direct contact, visit the study record on ClinicalTrials.gov .